kresmion.

Sanara MedTech Inc. (SMTI) relative valueRV

Compared with the rest of its industry group on the figures from its last annual filing.

SMTI's operating margin of 7.1% ranks in the 69th percentile of 17 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.

Kresmion ranks SMTI against its industry peers from annual SEC filings and market-price snapshots.

As of . Source: SEC EDGAR XBRL company facts. Method and limitations.

Against 18 Medical Instruments & Supplies peers

10-K FY to 31 Dec 2025 in USD
MetricSMTIPeer medianPercentilen
Revenue FY103M USD38.5M USD84th15
Revenue YoYn/an/an/a4
Gross margin92.7%59.8%97th16
Operating margin7.1%-11.1%69th17
Net margin-36.4%-6.4%42nd17
Return on equity-632.5%-16.2%3rd16
P / En/an/an/a4
1 year71.9%-15.2%92nd17

Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Fiscal periods ending between 2025-09-30 and 2026-06-30. Prices as of 2026-11-16. Every fundamental figure is one full fiscal year from one filing. Nothing is trailing twelve months and nothing is converted between currencies. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above. 0001493152-26-012352

Peer set, 18 companies

OSUR, EMBC, PDEX, UTMD, NNNN, ZJYL, AVR, KRMD, NYXH, STXS, MBOT, POCI, KMTS, BLFS, HBIO, NEPH, MLSS, STVN

Left out: DXR (no annual filing), AZTA (no annual filing), ZTEKF (no annual filing), DAVI (no annual filing), SHTPY (no annual filing), OBOCY (no annual filing), PLSE (no annual filing).

What could not be compared

  • 19 The filer did not report this line in the filing used.
  • 11 The denominator is zero or negative, so the ratio has no meaning.
  • 7 No annual filing (10-K, 20-F or 40-F) with fiscal-year figures.
  • 4 This filer reports an ordinary share count and trades as a depositary receipt at a ratio Kresmion does not store, so price times shares would be wrong.
  • 2 Reported in a different currency than the subject. A level in another currency is not comparable and is not converted here.
  • 2 Fewer than 5 peers carry a comparable value, so no median, quartile or percentile is published.
  • 2 The newest price is more than 10 days old.
  • 1 The filing's gross profit disagrees with its revenue minus cost of revenue, so one of the three figures is on another basis and no gross margin is shown.
  • 1 The share price jumped by a stock-split ratio after the filing this figure comes from, and no later filing has restated it on the new share basis yet, so price and per-share figures may be on different bases.

Free account

Open the relative value desk with a free account

An account turns this page into a research desk: thirty-one metrics over the whole peer set instead of eight, the distribution behind each median, the metric's history against the peer band, an editable peer set, and the filing behind every cell. The table above stays free.

Create a free accountSign in

Cite this data

Every fundamental figure is the full fiscal year reported on one annual SEC filing (10-K, 20-F or 40-F), named by accession. Peers are the company's industry group: the GICS sub-industry where the company is GICS-classified, otherwise the data vendor's industry label (the two label sets are not merged). A median, quartile or percentile is published only when at least five peers carry a comparable value, and a peer reporting in another currency is excluded from a level rather than converted. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above.

Upstream: SEC EDGAR XBRL company facts

Kresmion, "SMTI relative value, Kresmion", data as of 2026-03-24, https://kresmion.com/tools/relative-value/SMTI. Upstream data: SEC EDGAR XBRL company facts.

Link to this data (HTML):

<a href="https://kresmion.com/tools/relative-value/SMTI">SMTI relative value, Kresmion (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures